Literature DB >> 12742585

ICAM-1 can play a major role in mediating P. falciparum adhesion to endothelium under flow.

Carolyn Gray1, Christopher McCormick, Gareth Turner, Alister Craig.   

Abstract

We have investigated the importance of adhesion molecule co-operation in mediating Plasmodium falciparum adhesion to endothelial cells under flow conditions. Using three laboratory parasite lines and a patient isolate which differ in their ICAM-1 and CD36-binding avidity, we found that blockade of ICAM-1 and CD36 separately reduced IRBC adhesion by up to 95 and 50%, respectively. These results confirm previous data showing that ICAM-1 and CD36 synergize to mediate adhesion, but differ in demonstrating that without ICAM-1, binding under flow conditions is severely impaired. Thus, in this system, ICAM-1 is critical for P. falciparum adhesion to activated endothelium and once bound, synergy with CD36 mediates the majority (> or =98%) of adhesion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742585     DOI: 10.1016/s0166-6851(03)00075-6

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  45 in total

1.  Intercellular adhesion molecule 1-dependent activation of interleukin 8 expression in Candida albicans-infected human gingival epithelial cells.

Authors:  Hiroshi Egusa; Hiroki Nikawa; Seicho Makihira; Anahid Jewett; Hirofumi Yatani; Taizo Hamada
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1.

Authors:  Matthias Dormeyer; Yvonne Adams; Bernd Kramer; Srabasti Chakravorty; Man Tsuey Tse; Stefano Pegoraro; Lisa Whittaker; Michael Lanzer; Alister Craig
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Clonal variants of Plasmodium falciparum exhibit a narrow range of rolling velocities to host receptor CD36 under dynamic flow conditions.

Authors:  Thurston Herricks; Marion Avril; Joel Janes; Joseph D Smith; Pradipsinh K Rathod
Journal:  Eukaryot Cell       Date:  2013-09-06

4.  A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells.

Authors:  Marion Avril; Abhai K Tripathi; Andrew J Brazier; Cheryl Andisi; Joel H Janes; Vijaya L Soma; David J Sullivan; Peter C Bull; Monique F Stins; Joseph D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-22       Impact factor: 11.205

5.  Cytoadherence and severe malaria.

Authors:  Alister G Craig; Mohd Fadzli Mustaffa Khairul; Pradeep R Patil
Journal:  Malays J Med Sci       Date:  2012-04

6.  Temperature-Induced Catch-Slip to Slip Bond Transit in Plasmodium falciparum-Infected Erythrocytes.

Authors:  Ying Bena Lim; Juzar Thingna; Fang Kong; Ming Dao; Jianshu Cao; Chwee Teck Lim
Journal:  Biophys J       Date:  2019-11-22       Impact factor: 4.033

7.  Shape and Biomechanical Characteristics of Human Red Blood Cells in Health and Disease.

Authors:  Monica Diez-Silva; Ming Dao; Jongyoon Han; Chwee-Teck Lim; Subra Suresh
Journal:  MRS Bull       Date:  2010-05       Impact factor: 6.578

8.  Circulating non-transferrin-bound iron after oral administration of supplemental and fortification doses of iron to healthy women: a randomized study.

Authors:  Gary M Brittenham; Maria Andersson; Ines Egli; Jasmin Tajeri Foman; Christophe Zeder; Mark E Westerman; Richard F Hurrell
Journal:  Am J Clin Nutr       Date:  2014-07-23       Impact factor: 7.045

9.  Competitive endothelial adhesion between Plasmodium falciparum isolates under physiological flow conditions.

Authors:  Happy Phiri; Jacqui Montgomery; Malcolm Molyneux; Alister Craig
Journal:  Malar J       Date:  2009-09-21       Impact factor: 2.979

10.  Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment.

Authors:  Katie R Hughes; Giancarlo A Biagini; Alister G Craig
Journal:  Mol Biochem Parasitol       Date:  2009-10-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.